EV/EBITDA
-0.95
-0.02-2.15%
23 min ago
Summary
- As of February 7, 2025, SAGE EV/EBITDA is -0.95, with a fall of -0.02 (-2.15%) during the most recent trading day.
- Over the past year, SAGE EV/EBITDA has increased by +1.69 (+64.02%).
- SAGE EV/EBITDA is now -114.84% below its all-time high of 6.40.
Performance
SAGE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SAGE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -2.1% | +2.7% | +2.1% |
| 1 m1 month | -23.4% | +23.5% | +17.9% |
| 3 m3 months | -21.8% | +21.6% | +16.6% |
| 6 m6 months | -9.2% | -9.2% | -9.4% |
| ytdytd | -46.1% | +45.9% | +33.5% |
| 1 y1 year | +64.0% | -75.3% | -71.0% |
| 5 y5 years | +80.4% | -89.7% | -89.3% |
SAGE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -26.7% | -1.10 | +13.6% | |
| 3 m | 3-month | -0.56 | -69.6% | -1.10 | +13.6% |
| 6 m | 6-month | -0.56 | -69.6% | -1.18 | +19.5% |
| 1 y | 1-year | -0.56 | -69.6% | -2.70 | +64.8% |
| 3 y | 3-year | -0.56 | -69.6% | -5.82 | +83.7% |
| 5 y | 5-year | 6.40 | -114.8% | -8.59 | +88.9% |
| alltime | all time | 6.40 | -114.8% | -52.31 | +98.2% |
Sage Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.95(+46.2%) |
| 2024 | -0.65(-71.7%) |
| 2023 | -2.30(-39.6%) |
| 2022 | -3.81(-22.1%) |
| 2021 | -4.89(-189.9%) |
| 2020 | 5.44(-205.0%) |
| Date | Value |
|---|---|
| 2019 | -5.18(-52.8%) |
| 2018 | -10.97(-54.8%) |
| 2017 | -24.25(+123.9%) |
| 2016 | -10.83(-31.5%) |
| 2015 | -15.80(-34.1%) |
| 2014 | -23.99 |
FAQ
- What is Sage Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Sage Therapeutics?
- What is SAGE EV/EBITDA year-to-date change?
- What is Sage Therapeutics EV/EBITDA year-on-year change?
What is Sage Therapeutics EV/EBITDA?
The current EV/EBITDA of SAGE is -0.95
What is the all time high EV/EBITDA for Sage Therapeutics?
Sage Therapeutics all-time high EV/EBITDA is 6.40
What is SAGE EV/EBITDA year-to-date change?
Sage Therapeutics EV/EBITDA has changed by -0.30 (-46.15%) since the beginning of the year
What is Sage Therapeutics EV/EBITDA year-on-year change?
Over the past year, SAGE EV/EBITDA has changed by +1.69 (+64.02%)